Objectives
After participating in this educational activity, attendees should be able to:
1|Evaluate evidence-based clinical, ethical, legal, social, philosophical, quality-of-life, safety, and economic factors to make informed decisions that support optimal patient care.
Presenter(s):
Stephen Ryzewicz, MD
Committee Chair, moderator
Physician
Baystate Medical Center
Adam Pesaturo, PharmD
Pharmacy Coordinator
Pharmacist
Baystate Medical Center
Ashley McNamara, PharmD
PGY1 Pharmacy Resident
Pharmacist
Baystate Medical Center
Danielle Ellis, PharmD
PGY2 Critical Care Pharmacy Resident
Pharmacist
Baystate Medical Center
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Adam Pesaturo, PharmD | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Ashley McNamara, PharmD | Speaker | No relevant relationships with ineligible companies to disclose | Terbutaline for extavasation management |
| Danielle Ellis, PharmD | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Stephen Ryzewicz, MD | Moderator | No relevant relationships with ineligible companies to disclose | No |
Session date:
11/11/2025 - 12:00pm to 1:30pm EST
Location:
Baystate Medical Center / Zoom
759 Chestnut St
Springfield, MA
01199
United States
See map: Google Maps
Add to calendar:
- 1.50 ACPE Contact Hours
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC Contact Hours
- 1.50 BCIPE Risk Management
- 1.50 IPCE Credit Hour(s)
Facebook
X
LinkedIn
Forward